SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending amidst strong community anticipation for pivotal Phase 3 REGAL trial results for its GPS immunotherapy in AML, especially after the CEO's recent comments hinting at "curative outcomes." This fuels widespread speculation of an imminent Big Pharma buyout and a significant short squeeze, contrasting sharply with minority skepticism regarding the trial's blinded status and valuation.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is surging as intense short-covering and robust institutional accumulation are fueled by renewed optimism for its FDA-approved TIL therapy, Amtagvi, and imminent data readouts for pipeline expansion in lucrative oncology indications. The community widely anticipates a significant re-rating, potential international approvals, and strategic buyout interest, highlighting its perceived undervaluation.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is gaining attention as escalating geopolitical tensions, particularly regarding Iran and broader U.S.-China dynamics, intensify the focus on securing domestic heavy rare earth supplies for defense and high-tech industries. The community is actively anticipating the company's upcoming Bankable Feasibility Study, expected to re-rate its Greenland-based Tanbreez project's strategic value amidst calls for Western supply chain independence.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is trending with high anticipation for its upcoming earnings report, as its recent AIUC-1 certification highlights its role in secure enterprise AI agent orchestration, driving polarized community discussion and short-squeeze speculation.

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Edesa Biotech Inc

Edesa Biotech is trending following robust Phase 3 data for its ARDS treatment, which showed statistically significant mortality reduction. This positive clinical news, coupled with recent aggressive share purchases by the CEO and a new significant stake from Steven Cohen's Point72, is driving community speculation about potential buyouts or strategic partnerships.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending after reporting strong Q4 results that included robust e-commerce and advertising growth, a dividend increase, and a large share buyback, but also issued cautious forward guidance. This has led to a split community, with many bullish on its defensive nature and digital transformation, while others question its high valuation given the tempered outlook and its revenue milestone recently surpassed by Amazon.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is currently trending due to a sharp market rebound following President Trump's remarks suggesting the Iran war is "very complete," which also triggered a substantial reversal in oil prices, despite widespread community speculation about it being a "Trump pump" or market manipulation.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is trending as it secures multiple significant contracts in nuclear energy, including SMR deployments and European research sites, alongside its crucial role in NASA's Artemis II mission, driving bullish long-term growth expectations backed by its substantial backlog. However, some investors express frustration over the stock's price action, labeling it "trash" and questioning its immediate upward momentum despite positive developments.

Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.

Americas Gold and Silver Corp

Americas Silver Corp

Americas Silver (USAS) is trending as silver prices surge amid strong industrial demand and geopolitical tensions, with a significant community focus on perceived market manipulation. The company's strategic joint venture for North America's first commercial antimony processing facility and increasing silver production are key talking points for investors anticipating future upside.

SSgA Active Trust - State Street SPDR Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF is experiencing a significant rally amid reports and community chatter suggesting a potential de-escalation or end to the Iran war, which is also driving a sharp drop in oil prices and sparking discussions of a broad market short squeeze among traders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update

Agenus Inc. (Agenus) (Nasdaq: AGEN), a leader in immuno-oncology, today announced that the Company will release its fourth quarter and year-end 2025 financial results before the market opens on...

Agenus (AGEN) to Release Earnings on Tuesday

Agenus (NASDAQ:AGEN) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 10. (View Earnings Report at...

Agenus Inc. (NASDAQ:AGEN) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Agenus Inc. (NASDAQ:AGEN - Get Free Report) have been assigned an average rating of "Hold" from the five research firms that are covering the company, Marketbeat reports. One investment...

Agenus Presents Biomarker Data Demonstrating Survival Stratification in MSS mCRC and Other Immunologically Cold Tumors Treated with BOT+BAL

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced new translational and clinical biomarker data from its Phase 1b C-800-01 trial (NCT03860272) evaluating botensilimab (BOT), an...

Agenus to Present New Data at AACR-IO Exploring Systemic and Tumor Inflammation Biomarkers with BOT/BAL in Immunologically Cold Tumors

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that new translational and clinical biomarker analyses from its botensilimab (BOT) immunotherapy program have been accepted...

Agenus Inc. (NASDAQ:AGEN - Get Free Report) has earned an average recommendation of "Hold" from the five analysts that are currently covering the company, MarketBeat Ratings reports. One analyst has...

Agenus Webcast: Zydus Manufacturing Deal Closes, France Access Expands, Phase 3 BATMAN Nears Launch

Agenus (NASDAQ:AGEN) used its first 2026 stakeholder webcast to outline operational and clinical priorities tied to its botensilimab/balstilimab (BOT/BAL) immunotherapy program, highlighting a...

Agenus Expands Medical Affairs Infrastructure to Support Increasing Physician Requests for Authorized Access to Botensilimab Plus Balstilimab

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the expansion of its global Medical Affairs infrastructure and early-access support capabilities in response to...

Agenus to Host First 2026 Stakeholder Webcast

Agenus Inc. (Agenus) (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will host its first Stakeholder Webcast of 2026, Access to Acceleration: Agenus Global Momentum Entering 2026 on...

Agenus Inc. (NASDAQ:AGEN) Sees Significant Increase in Short Interest

Agenus Inc. (NASDAQ:AGEN - Get Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest totaling 3,399,217 shares, an increase of...

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

AGEN
Agenus Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AGEN News

AGENAgenus Inc